Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
52
PharmaCompass offers a list of Sotagliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sotagliflozin manufacturer or Sotagliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sotagliflozin manufacturer or Sotagliflozin supplier.
PharmaCompass also assists you with knowing the Sotagliflozin API Price utilized in the formulation of products. Sotagliflozin API Price is not always fixed or binding as the Sotagliflozin Price is obtained through a variety of data sources. The Sotagliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sotagliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sotagliflozin, including repackagers and relabelers. The FDA regulates Sotagliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sotagliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sotagliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sotagliflozin supplier is an individual or a company that provides Sotagliflozin active pharmaceutical ingredient (API) or Sotagliflozin finished formulations upon request. The Sotagliflozin suppliers may include Sotagliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Sotagliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sotagliflozin DMF (Drug Master File) is a document detailing the whole manufacturing process of Sotagliflozin active pharmaceutical ingredient (API) in detail. Different forms of Sotagliflozin DMFs exist exist since differing nations have different regulations, such as Sotagliflozin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sotagliflozin DMF submitted to regulatory agencies in the US is known as a USDMF. Sotagliflozin USDMF includes data on Sotagliflozin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sotagliflozin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sotagliflozin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sotagliflozin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sotagliflozin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sotagliflozin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sotagliflozin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sotagliflozin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sotagliflozin suppliers with NDC on PharmaCompass.
Sotagliflozin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sotagliflozin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sotagliflozin GMP manufacturer or Sotagliflozin GMP API supplier for your needs.
A Sotagliflozin CoA (Certificate of Analysis) is a formal document that attests to Sotagliflozin's compliance with Sotagliflozin specifications and serves as a tool for batch-level quality control.
Sotagliflozin CoA mostly includes findings from lab analyses of a specific batch. For each Sotagliflozin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sotagliflozin may be tested according to a variety of international standards, such as European Pharmacopoeia (Sotagliflozin EP), Sotagliflozin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sotagliflozin USP).
